
ZYME vs SRPT
$ZYME vs $SRPT head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ZYME vs SRPT: the quick read
- ·ZYME is the larger company by market cap ($2.03B vs $1.98B).
- ·SRPT has been more active on our scanner (123 vs 40 alerts in 30 days).
- ·ZYME has the smaller float (45.2M vs 105.6M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·SRPT draws far more of our scanner's attention, 123 unusual-volume alerts in 30 days against 40, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ZYME and SRPT on TheDesperateTrader.
- Is ZYME or SRPT the better stock?
- "Better" depends on your goal, and these two are not alike. ZYME is the larger company by market cap ($2.03B vs $1.98B). SRPT has been more active on our scanner (123 vs 40 alerts in 30 days). ZYME has the smaller float (45.2M vs 105.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ZYME and SRPT?
- The differences that matter: they are similar in size ($2.03B vs $1.98B); they trade at very different share prices ($28.93 vs $18.22); ZYME sits at 95% of its 52-week range against 33% for SRPT; our scanner flagged ZYME 40 times in the last 30 days against 123 for SRPT. Everything above is measured from the latest completed session and SEC filings.
- Which of ZYME and SRPT is more active right now?
- Right now ZYME is at about 1.7x its normal volume and SRPT is at about 0.6x, so ZYME is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ZYME or SRPT? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.